Musolino, Vincenzo
Gliozzi, Micaela
Scarano, Federica
Bosco, Francesca
Scicchitano, Miriam
Nucera, Saverio
Carresi, Cristina
Ruga, Stefano
Zito, Maria Caterina
Maiuolo, Jessica
Macrì, Roberta
Amodio, Nicola
Juli, Giada
Tassone, Pierfrancesco
Mollace, Rocco
Caffrey, Rebecca
Marioneaux, Jonathon
Walker, Ross
Ehrlich, James
Palma, Ernesto
Muscoli, Carolina
Bedossa, Pierre
Salvemini, Daniela
Mollace, Vincenzo
Sanyal, Arun J.
Article History
Received: 1 July 2019
Accepted: 29 January 2020
First Online: 13 February 2020
Competing interests
: AJS is President of Sanyal Bio. He has stock options in Genfit, Galmed, Exhalenz, Durect, Tiziana and Indalo. He has served as a consultant to Intercept, Gilead, Bristol Myers Squibb, Novartis, Pfizer, Lilly, Novo Nordisk, Astra Zeneca, Medimmune, Merck, Allergan, Albireo, Affimmune, Birdrock, Boehringer Ingelhiem, Artham, Celgene, Conatus, Genentech, Tern, Sundise Pharmaceuticals, Takeda, Hemoshear, Immuron, Surrozen, Poxel, Prosciento, Second Genome, Liposcience, Cymabay, Salix, Ferring and Teva. His institution has received grants from Inercept, Gilead, Novartis, Merck, Salix and Bristol Myers Squibb. Rebecca Caffrey is the Co-founder, part-owner and employee of Sanyal Bio. Jonathan Marionaux is employed by Sanyal Bio. All other authors have nothing to disclose.